How much funding has Acceleron raised?

Acceleron has raised $10.0M in total funding, most recently a Series G+ round.

Who are Acceleron's investors?

Acceleron's investors include Bessemer VP.

Where is Acceleron headquartered?

Acceleron is headquartered in Cambridge, Massachusetts, United States.

How many employees does Acceleron have?

Acceleron has 201-500 employees.

Acceleron

Acquired

Cambridge, United States · Founded 2003 · $10.0M raised

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2003
Business Model: B2B

Total Funding: $10.0M
Last Round: $10.0M Series G+Jun 2010
Rounds: 1

About

Acceleron Pharma, Inc. was an American clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on discovering and developing protein therapeutics that regulate the TGF-beta superfamily of proteins involved in cell and tissue growth and repair. Its pipeline included luspatercept for anemia and sotatercept for pulmonary arterial hypertension, developed in partnership with Celgene. Acceleron went public on Nasdaq (XLRN) in 2013 and was acquired by Merck & Co. for $11.5 billion in November 2021, becoming a wholly owned subsidiary.

Summary

Acceleron is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $10.0M in total across 1 round, most recently a $10.0M Series G+ round in Jun 2010. Investors include Bessemer VP.